Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cell Biol ; 20(12): 4359-70, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10825199

ABSTRACT

Assembly of enhanceosomes requires architectural proteins to facilitate the DNA conformational changes accompanying cooperative binding of activators to a regulatory sequence. The architectural protein HMG-1 has been proposed to bind DNA in a sequence-independent manner, yet, paradoxically, it facilitates specific DNA binding reactions in vitro. To investigate the mechanism of specificity we explored the effect of HMG-1 on binding of the Epstein-Barr virus activator ZEBRA to a natural responsive promoter in vitro. DNase I footprinting, mutagenesis, and electrophoretic mobility shift assay reveal that HMG-1 binds cooperatively with ZEBRA to a specific DNA sequence between two adjacent ZEBRA recognition sites. This binding requires a strict alignment between two adjacent ZEBRA sites and both HMG boxes of HMG-1. Our study provides the first demonstration of sequence-dependent binding by a nonspecific HMG-box protein. We hypothesize how a ubiquitous, nonspecific architectural protein can function in a specific context through the use of rudimentary sequence recognition coupled with cooperativity. The observation that an abundant architectural protein can bind DNA cooperatively and specifically has implications towards understanding HMG-1's role in mediating DNA transactions in a variety of enzymological systems.


Subject(s)
Carrier Proteins/genetics , DNA/genetics , Gene Expression Regulation , High Mobility Group Proteins/genetics , Nucleoproteins/genetics , Animals , DNA/chemistry , HMGB1 Protein , Mutation , Nucleic Acid Conformation , Promoter Regions, Genetic , Recombinant Proteins/genetics
2.
J Biol Chem ; 273(2): 932-9, 1998 Jan 09.
Article in English | MEDLINE | ID: mdl-9422752

ABSTRACT

Activation of RNA polymerase II transcription in vivo and in vitro is synergistic with respect to increasing numbers of activator binding sites or increasing concentrations of activator. The Epstein-Barr virus ZEBRA protein manifests both forms of synergy during activation of genes involved in the viral lytic cycle. The synergy has an underlying mechanistic basis that we and others have proposed is founded largely on the energetic contributions of (i) upstream ZEBRA binding to its sites, (ii) the general pol II machinery binding to the core promoter, and (iii) interactions between ZEBRA and the general machinery. We hypothesize that these interactions form a network for which a minimum stability must be attained to activate transcription. One prediction of this model is that the energetic contributions should be reciprocal, such that a strong core promoter linked to a weak upstream promoter would be functionally analogous to a weak core linked to a strong upstream promoter. We tested this view by measuring the transcriptional response after systematically altering the upstream and core promoters. Our data provide strong qualitative support for this hypothesis and provide a theoretical basis for analyzing Epstein-Barr virus gene regulation.


Subject(s)
Promoter Regions, Genetic , RNA Polymerase II/metabolism , Transcription, Genetic , Binding Sites , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Substrate Specificity , Trans-Activators/genetics , Trans-Activators/metabolism , Viral Proteins/genetics , Viral Proteins/metabolism
3.
Mol Cell Biol ; 15(3): 1536-44, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7862146

ABSTRACT

Cell transformation by nuclear oncogenes such as c-myc presumably involves the transcriptional activation of a set of target genes that participate in the control of cell division. The function of a small evolutionarily conserved domain of the c-myc gene encompassing amino acids 129 to 145 was analyzed to explore the relationship between cell transformation and transcriptional activation. Deletion of this domain inactivated the c-myc oncogene for cell transformation while retaining the ability to activate transcription of either myc consensus binding sites or a GAL4-dependent promoter when the c-myc N-terminus was fused to the GAL4 DNA-binding domain. Point mutations that altered a conserved tryptophan (amino acid 136) within this domain had similar effects. Expression of the wt c-Myc N terminus (amino acids 1 to 262) as a GAL4 fusion was a dominant inhibitor of cell transformation by the c-myc oncogene, and this same domain also inhibited transformation by the adenovirus E1A gene. Surprisingly, deletion of amino acids 129 to 145 eliminated the dominant negative activity of GAL4-Myc on both c-myc and E1A transformation. Expression of the GAL4-Myc protein in Cos cells led to the formation of a specific complex between the Myc N terminus and a nuclear factor, and this complex was absent with the dl129-145 mutant. These results suggest that an essential domain of the c-Myc protein interacts with a specific nuclear factor that is also required for E1A transformation.


Subject(s)
Adenovirus E1A Proteins/metabolism , Cell Transformation, Neoplastic , Genes, myc , Nuclear Proteins/metabolism , Proto-Oncogene Proteins c-myc/metabolism , Saccharomyces cerevisiae Proteins , Transcription Factors , Adenovirus E1A Proteins/genetics , Animals , Base Sequence , Binding Sites , Cell Line , Cell Nucleus/metabolism , Consensus Sequence , DNA/chemistry , DNA/metabolism , DNA-Binding Proteins , Fungal Proteins/biosynthesis , Fungal Proteins/metabolism , HeLa Cells , Humans , Mice , Molecular Sequence Data , Oligodeoxyribonucleotides , Rats , Recombinant Fusion Proteins/biosynthesis , Transcription, Genetic , Transcriptional Activation
SELECTION OF CITATIONS
SEARCH DETAIL
...